The global yellow fever vaccines market is expected to grow at a significant CAGR during the forecast period (2021-2027). Yellow fever is a flavivirus disease spread by mosquitos that is found in tropical areas of Sub-Saharan Africa, South America, Central America, and the Caribbean. Yellow fever is a virus that is closely related to West Nile Virus. Yellow fever is carried by mosquitos that are active and bite throughout the day. It is not a contagious disease that spreads from one afflicted person to another. Yellow fever is spreading globally as a result of decreasing immunity among the local population, climate change, and high-density urbanisation. 

According to the CDC, 15% of persons who contract yellow fever develop a serious and fatal condition. Yellow fever is more common in particular places of Africa and Latin America, putting travellers in danger. Chills, fever, back pain, severe headache, exhaustion and weakness, as well as nausea and vomiting, are all symptoms of yellow fever. Yellow fever has no specific therapy, however, symptoms can be managed as the body battles the virus. According to the World Health Organization, over 200,000 cases of yellow fever occur each year. Vaccines are the only therapy for yellow fever, and they provide lifelong protection. Yellow fever vaccination is carried out to prevent the disease from spreading internationally and to protect individual travellers who may be exposed to the disease. Increased yellow fever prevalence, unclean lifestyle, and increased community awareness of yellow fever therapy. The global market for yellow fever vaccines is driven by improving healthcare infrastructure in certain growing nations such as Brazil and an increase in the number of travellers visiting endemic countries. 

The global yellow fever vaccine market is growing due to increased efforts by the World Health Organization and UNICEF. Furthermore, the global market for yellow fever treatment is driven by long-term agreements with manufacturers to offer vaccination and routine programmes, as well as emergency and preventive efforts. However, the yellow fever vaccine market's growth is hampered by a lack of supply to satisfy rising demand.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: AJ Vaccines, Bionet-Asia, GlaxoSmithKline plc (GSK), Johnson & Johnson among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Yellow Fever Vaccines Market by Segment

By End-User 

• Hospitals

• Clinics

• Point of Care Centers 

Global Yellow Fever Vaccines Market by Region